Back to search
🇺🇸

United States · US · US:64980-729_f6c34864-dbd6-436e-b1e5-b1feaa61696a

PHOSPHA 250 NEUTRAL

In shortageSPLATC C03CB

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerRising Pharma Holdings, Inc.
CountryUS (United States)
ATC codeC03CB
Dispensing
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs · 1

  • ndc11
    6498072901
    100 TABLET in 1 BOTTLE (64980-729-01)

Annotations

DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Potassium Chloride Tablet, Extended Release
Raw payload (JSON)
{
  "route": "ORAL",
  "spl_meta": {
    "9432adfc-6add-4ab4-ae93-2e2daf348be2": {
      "match": "brand_token",
      "title": "PHOSPHA 250 NEUTRAL (DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE) TABLET [RISING PHARMA HOLDINGS, INC.]",
      "spl_version": "1",
      "published_date": "2026-03-30"
    }
  },
  "productid": "64980-729_f6c34864-dbd6-436e-b1e5-b1feaa61696a",
  "productndc": "64980-729",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "POTASSIUM PHOSPHATE, MONOBASIC; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",
  "shortage_reason": "Potassium Chloride Tablet, Extended Release",
  "shortage_status": "current",
  "proprietary_name": "PHOSPHA 250 NEUTRAL",
  "active_ingred_unit": "mg/1; mg/1; mg/1",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER",
  "nonproprietary_name": "Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate",
  "start_marketing_date": "20260328",
  "active_numerator_strength": "155; 852; 130"
}

Related drugs

Other records sharing ATC code C03CB.

Access this data programmatically

Query PHOSPHA 250 NEUTRAL and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.